Introduction
Acute lymphoblastic leukemias (ALL)' are presumed to result from clonal expansion of particular stages of developing lymphoid cells and provide unique opportunities to analyze molecular events associated with lymphoid cell differentiation at a clonal level. Molecular analyses of these cells have allowed the description and characterization of gene rearrangement and transcription providing models for the developmental hierarchy of immunoglobulin and T cell receptor (TCR) gene activation (1-10).
The T cell antigen receptor or Ti heterodimer, consists of the TCR-a and # chains, which are encoded by functionally rearranged TCR-a and TCR-(i genes, respectively (11) (12) (13) (14) . In 1 . Abbreviations used in this paper: ALL, acute lymphoblastic leukemia; C, constant; D, diversity; J, joining; TCR, T cell receptor; V, variable.
close association with Ti are at least three polypeptides (CD3-'y, CD3-6, and CD3-E). Together, these proteins form the core of the antigen-specific TCR, the CD3-a/ff complex (15, 16) . Recently, the protein product of a third rearranging gene TCR-'y has been identified (17, 18) . This protein can be expressed in association with the CD3 complex on the cell surface together with TCR-6 in the absence of the a/, heterodimer (19, 20) . However, it is still uncertain whether cells expressing the TCR-'y and a polypeptides belong to the same lineage as T cells expressing the CD3-a/# complex.
Developmental studies in the murine fetus suggest that TCR-'y gene rearrangement and expression occur first, followed by TCR-(t gene rearrangement and expression. Thereafter, during further differentiation, transcription of the TCR-y gene decreases, while TCR-a transcription increases (21) (22) (23) (24) (25) (26) . Moreover, as shown in T-ALL cells, the CD3 proteins can combine with TCR-,B protein in the cytoplasm of CD3-immature cells, whereas TCR-a transcripts and protein have only been observed in CD3+ cells (27) (28) (29) (30) . Expression ofthe TCR-a gene may thus serve as the critical regulatory event in the formation of the CD3-Ti complex at the cell surface (26 Southern blot hybridization. High molecular weight DNA was prepared from mononuclear cells and digested with appropriate restriction endonucleases. The digested DNA was electrophoresed through 0.6-0.9% agarose slab gels, and transferred to nylon membranes. Blots were hybridized to probes labeled to -2 X 109 cpm/yg with 32Pby the random primer method (34) . The TCR-a gene probes used in this study included five genomic Ja probes. A diagram of TCR-a gene J region and these probes is shown in Fig. 1 . The JaC and JaD probes (4.7-and 2.0-kb fragments, respectively) were described previously (35) . Probes JaE, JaF, and JaG (4.0-, 1.5-, and 6.7-kb fragments, respectively) were isolated in the laboratory of M. Minden. The description of the isolation of these clones and a detailed map will be published elsewhere (Champagne E., and M. Minden, unpublished observations). Each DNA fragment contains several Ja segments. As shown in Fig. 1 Northern blot hybridization. Cytoplasmic RNA was extracted after lysis with NP-40 in the presence of 10 mM vanadyl-ribonucleoside complex and removal of nuclei from 11 T-ALL samples and the three T cell lines, as described previously (36) . 10Mg of RNA was denatured in formamide, electrophoresed in 1% agarose containing formaldehyde, and transferred to nylon membranes. After hybridization, blots were washed in high stringency conditions (0. IX SSC and 0.2% SDS) (37) . The probes used in this study were as follows: TCR-'y, HGPO3 1.4 kb cDNA (38); C# (described above); Ca, pGA-5 0.35 kb Sau 3a-Hind III cDNA fragment provided by J. Kappler (14) ; and CD3-'y, 0.6 kb cDNA (38) .
Results
DNA analysis. All T-ALL patients had rearrangements ofboth the TCR-y and # genes, as described previously (5, 7) . The 4 showed rearrangement of the TCR-a gene. These rearrangements were detected with the JaF and JaG probes. The remaining three patients (patients 1-3) and the three patients (5-7) in stage II had no rearrangements. Three samples from patients 9, 11, and 12 classified as stage III demonstrated TCR-a gene rearrangements. In two of these (patients 9 and 12), a single rearranged band was observed after hybridization with the JaG probe. In patient 11, the JaF and JaG sequences were deleted with retention of the JaE sequences on both alleles indicating the usage of Ja segments located between the JaE and JaF sequences. After Bam HI digestion, patient 8 showed a rearranged band correspond- Stage JaC JaD JaE JaF JaG JcxF _m -wo a _ JaG Ck fd0u.
_C-e sponding to the JaE, JaF, and JaG probes, respectively, on the gels. DNAs were digested with Hind III (A) or Bam HI (B) and were hybridized with the JaF and JaG probes at the same time (upper column). After stripping, these blots were hybridized with the CA(A) or CK(B) and JaE probes at the same time (lower column). In cases where rearranged Ja bands were demonstrated, the rearranged band was reprobed using single Ja probes. and/or rearranged bands corresponding to the JaG probe with retention of the JaF sequences on both alleles. In patient 15, the JaD sequences and Ja regions located upstream of these were deleted on one allele and the JaG sequences were deleted on the other allele. Patient 16 showed a rearranged band that hybridized with the JaF probe, whereas the JaG sequences were deleted on a single allele. In patient 17, rearranged bands corresponding to the JaE and JaF probes were observed.
All three leukemic T cell lines examined also had TCR-a gene rearrangements on both alleles. The CD3-T cell line HSB2 only expressed the CD2 and CD7 antigens suggesting derivation from an immature stage. These cells showed a single rearranged band corresponding to the JaG probe with a deletion of the other allele. CEM and MOLT4 cells also did not express the CD3 antigen and demonstrated rearrangements ofboth alleles ofthe TCR-a gene. In CEM, a rearranged band and a deletion corresponding to the JaE probe were observed. MOLT4 showed complete deletion of regions corresponding to the JaD probes with biallelic retention of the JaC sequences.
Overall, among the CD3-cells, one (14%) of seven stage I and II patients and all three leukemic T cell lines showed rearrangements of the TCR-a gene on both alleles. Among the stage III patients, three (43%) had rearrangements. In two of these, a single allele was involved and in the remaining patient both alleles were rearranged. All five stage IV patients had TCR-a gene rearrangements and four of five showed rearrangements on both alleles. RNA analysis. To analyze the transcription of TCR genes, Northern blot analyses were performed on total cytoplasmic RNA from 11 patients (three stage I, four stage III, and four stage IV patients) where sufficient material was available and from all three T cell lines. The results are summarized in Table  II and representative blots are shown in Fig. 3 .
Transcription of the TCR-y gene was analyzed in 10 patients and the three T cell lines. Two RNA samples (patients 11 and 19) contained no TCR-y transcripts, while 1.7-kb TCR-y transcripts were observed in all other samples. In patient 1, a 1.3-kb TCR-,y transcript was detected in addition to the 1.7-kb transcript. All three T cell lines also expressed 1.7-kb TCR-y transcripts. However, the levels were very low in CEM and MOLT4.
All 11 patients and three T cell line samples contained 1.0-and/or 1.3-kb transcripts of the TCR-,B gene. The 1.3-kb transcript is derived from VDJ,B recombination, while the 1.0 kb does not contain V region transcripts (39) . In two (patients 2 and 4) stage I patients, 1.3-kb transcripts were present and in the remaining stage I patient (patient 1), only a 1.0-kb transcript was observed. 1.3-kb TCR-,B transcripts were present in seven of eight patients classified as stage III and IV, while one (patient 10) possessed only a 1.0-kb transcript.
Hybridization with the Ca probe revealed 1.3-and/or 1.6-kb transcripts in 8 of the 11 patients. The 1.6-kb transcript encodes the complete TCR-a polypeptide, however, the 1.3-kb transcript is presumably immature (40) . No TCR-a transcripts were observed in the three CD3-patients (stage I) tested nor in the CD3-cell lines. In contrast, RNA from all eight CD3+ patients contained 1.6-kb transcripts, however, the levels of TCR-a transcripts varied compared to TCR-4 transcripts and were relatively low in patients 10, 12, and 17.
Finally, one component of the CD3 complex, CD3-y was .11-1-
Based on the expression of the CDl and CD3 antigens, the patients with T-ALL studied here were divided into four subgroups; stage I, CDl-, CD3-; stage II, CD1+, CD3-; stage III, CD1+, CD3+; and stage IV, CD1-, CD3+. These subgroups represent the various stages of T cell differentiation. All five group IV T-ALL patients had rearrangements involving Ja segments between the JaG sequences and Ca, but only three of seven stage III and one of seven stage I and II patients were found to be rearranged in the area between JaG and Ca. Thus, it is possible that the more immature T cells initially rearrange to Ja regions furthest away from Ca and during development the cells successively rearrange in a 5' to 3' direction with the most mature cells utilizing the 3' most Ja regions. Indeed, in 75% of functional T cell clones TCR-a gene rearrangements were reported in Ja regions downstream of the JaD sequences (35) . This provides further support that the frequency of usage of Ja segments close to Ca increases during thymic differentiation. Recently, similar findings were observed with the TCR-,y gene; usage of the most upstream Jy segment is more frequent in thymocytes than in mature T cells (41) . In an Abelson murine leukemia virus transformed pre-B cell line, a secondary rearrangement event was observed, characterized by formation of a new DJH complex accompanied by deletion of the existing DJH rearrangement on the same allele (42) . Thus, it seems that after the first Via recombination, during thymic selection, a secondary rearrangement might occur between a Va located 5' and a Ja segment located 3' of the first Via complex, with the concomitant deletion ofthe preexisting VJa complex. This hypothesis is strengthened by the observation of a change in immunoglobulin antigen specificity when a second 5' VH recombined into an existing VDJH complex in murine B cells (43, 44 (45) and in humans (46) . In humans, this constant gene was located 90 kb 5' to Ca. Since the Ja probes used in this study were not capable of detecting TCR-a gene rearrangements occurring between putative Cb and JaG sequences, it is possible that these cells had TCR-a gene rearrangements in this region. Alternatively, the y/6 heterodimer may be expressed together with the CD3 antigen on the cell surface and the rearrangements of the TCR-6 gene may have occurred with retention of germline configuration ofthe TCR-a gene. It will be important to examine these patients using additional probes as they become available in order to delineate the mechanism of TCR-a and TCR-6 gene rearrangements.
In T-ALL with the most immature phenotype (stage I), patient 4 had rearrangements ofthe TCR-a gene as did the cell lines HSB2, CEM, and MOLT4, which are representative of immature stages of T cell development. In these samples, no TCR-a transcripts were expressed in spite ofTCR-a gene rearrangement suggesting that these rearrangements alone were not sufficient for the expression of the TCR-a gene. In contrast, all T-ALL tested, as well as the three T cell lines, had both rearrangements and transcripts ofthe TCR-, gene and no discordance was observed. Thus, the system for TCR-a gene activation appeared quite different from that for activation of the TCR-,B gene. One explanation for the discordance between rearrangement and expression of the TCR-a gene is that the type of rearrangement observed may be incomplete. Alternatively, activation of a regulatory system may be required for TCR-a expression. Shackelford et al. observed that TCR-a transcripts were induced by TPA in CD3-subclones of CEM (47) . Moreover, induction of TCR-a transcripts by TPA are enhanced by incubation with cycloheximide (unpublished data), indicating that specific proteins may regulate the transcription of the TCR-a gene and/or the degradation of TCR-a transcripts.
In murine fetal tissue, TCR-,y transcription precedes transcription of TCR-# and TCR-a, thereafter, it decreases in inverse proportion to TCR-a transcription during thymic development (21) (22) (23) (24) (25) (26) . In this study, however, most of stage III and IV T-ALL had TCR-'y transcripts. These events, similar to CD3-6 and CD3-E, in T cell differentiation (27) (28) (29) . Thus, the detection of CD3-y provides a useful marker for assignment of cell lineage in leukemias of ambiguous phenotype. In summary, most T-ALL and leukemic T cell lines tested expressed TCR-y transcripts and all samples expressed TCR-# and CD3-y transcripts. TCR-ca transcripts were confined to CD3' T-ALL and the majority of CD3+ T-ALL also showed rearrangement of the TCR-a gene. However, TCR-a gene rearrangements were observed even in CD3-T-ALL and in T cell lines contaihing no TCR-a transcripts. These leukemic cells may represent a transient stage between rearrangement and expression and provide an opportunity for determining the mechanism regulating the expression of the TCR-a gene.
